Comparison of therapeutic effectiveness of combined interventional therapy for 1126 cases of primary liver cancer

Table 1 Clinical data of 1126 patients

Group	Cases(n)	Size of tumor (cm)			Clinical staging			Liver function level
		< 5	5-10	> 10	I	II	III	A	B	C
Preop. TACE	258	20	145	93	104	154	0	155	103	0
Postop.TACE	154	9	76	69	16	138	0	83	71	0
TACE + RFA	126	3	57	66	48	57	21	92	34	0
TACE	469	31	239	199	156	251	62	252	197	20
TAI	119	11	47	61	28	47	44	14	73	32
Total	1126	74	564	488	352	647	127	596	478	52

Table 2 Clinical data of 1126 patients

Group	Cases(n)	Karnofsky scores		HBsA	AVF		Embolus in PV
		0-80	80-100	(+)	HV	PV	Right	Left
Preop. TACE	258	172	86	221	9	19	67	73
Postop.TACE	154	98	56	124	4	10	21	16
TACE + RFA	126	83	43	107	12	27	32	26
TACE	469	291	178	412	76	125	106	92
TAI	119	78	41	101	22	34	32	28
Total	1126	722	404	965	123	215	258	235

Table 3 Accumulated survival rate for 874 HCC patients after various kinds of interventional therapy

Group	Cases(n)	1 yr		3 yr		5 yr
		Cases(n)	Survivalrate (%)	Cases(n)	Survivalrate (%)	Cases(n)	Survivalrate (%)
Preop. TACE	198	148/198	74.7	82/198	41.4	58/157	36.9
Postop.TACE	114	90/114	78.9	46/114	40.4	33/88	37.5
TACE + RFA	106	79/106	74.5	39/106	36.8	-	-
TACE	387	268/387	69.3	84/387	21.7	26/309	8.4
TAI	69	8/69	11.6	0/69	0	0/69	0
Total	874	593/874	67.8	251/874	28.7	117/623	18.8

Table 4 Therapeutic effect of TACE+RAF, TACE and TAI in 562 patients

Group	Cases (n)	PR	NC	PD	Effective rate (%)
TACE + RFA	106	73	26	7	93.4
TACE	387	276	46	65	83.2
TAI	69	8	11	50	27.5
Total	562	357	83	122	81.5

Table 5 Changes of indexes before and after interventional therapy n (%)

Group	Index
	Degrade ofChild liverfunction	Blackout ofblood flowinside tumor	Blackout ofblood flowaround tumor	RecoveryofAFP
TACE + RFA	33/106 (31.1)	59/106 (55.7)	54/106 (50.9)	49/106 (46.2)
TACE	119/387 (30.7)	212/387 (54.8)	189/387 (48.8)	174/387 (45.0)
TAI	23/69 (33.3)	0/69 (0)	0/69 (0)	0/69 (0)
Total	175/562 (31.1)	271/562 (48.2)	243/562 (43.2)	223/562 (39.7)